A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.

Landete P, Caliman-Sturdza OA, Lopez-Martin JA, Preotescu L, Luca MC, Kotanidou A, Villares P, Iglesias SP, Guisado-Vasco P, Saiz-Lou EM, Del Carmen Farinas-Alvarez M, de Lucas EM, Perez-Alba E, Cisneros JM, Estrada V, Hidalgo-Tenorio C, Poulakou G, Torralba M, Fortun J, Garcia-Ocana P, Lemaignen A, Marcos-Martin M, Molina M, Paredes R, Perez-Rodriguez MT, Raev D, Ryan P, Meira F, Gomez J, Torres N, Lopez-Mendoza D, Jimeno J, Varona JF

Open source

DOI
10.1093/cid/ciae227
Published
2024 Oct 15
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciae227,
  title = {A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.},
  author = {Landete P and Caliman-Sturdza OA and Lopez-Martin JA and Preotescu L and Luca MC and Kotanidou A and Villares P and Iglesias SP and Guisado-Vasco P and Saiz-Lou EM and Del Carmen Farinas-Alvarez M and de Lucas EM and Perez-Alba E and Cisneros JM and Estrada V and Hidalgo-Tenorio C and Poulakou G and Torralba M and Fortun J and Garcia-Ocana P and Lemaignen A and Marcos-Martin M and Molina M and Paredes R and Perez-Rodriguez MT and Raev D and Ryan P and Meira F and Gomez J and Torres N and Lopez-Mendoza D and Jimeno J and Varona JF},
  year = {2024},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciae227},
  url = {https://doi.org/10.1093/cid/ciae227}
}

RIS

TY  - JOUR
TI  - A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.
AU  - Landete P
AU  - Caliman-Sturdza OA
AU  - Lopez-Martin JA
AU  - Preotescu L
AU  - Luca MC
AU  - Kotanidou A
AU  - Villares P
AU  - Iglesias SP
AU  - Guisado-Vasco P
AU  - Saiz-Lou EM
AU  - Del Carmen Farinas-Alvarez M
AU  - de Lucas EM
AU  - Perez-Alba E
AU  - Cisneros JM
AU  - Estrada V
AU  - Hidalgo-Tenorio C
AU  - Poulakou G
AU  - Torralba M
AU  - Fortun J
AU  - Garcia-Ocana P
AU  - Lemaignen A
AU  - Marcos-Martin M
AU  - Molina M
AU  - Paredes R
AU  - Perez-Rodriguez MT
AU  - Raev D
AU  - Ryan P
AU  - Meira F
AU  - Gomez J
AU  - Torres N
AU  - Lopez-Mendoza D
AU  - Jimeno J
AU  - Varona JF
PY  - 2024
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciae227
UR  - https://doi.org/10.1093/cid/ciae227
ER  - 

APA

P, L., OA, C., JA, L., L, P., MC, L., A, K., P, V., SP, I., P, G., EM, S., M, D. C. F., EM, D. L., E, P., JM, C., V, E., C, H., G, P., M, T., J, F., P, G., A, L., M, M., M, M., R, P., MT, P., D, R., P, R., F, M., J, G., N, T., D, L., J, J., & JF, V. (2024). A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciae227

Source records